These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35719366)

  • 1. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
    Pei LP; Zhang YZ; Li GY; Sun JL
    Front Genet; 2022; 13():890591. PubMed ID: 35719366
    [No Abstract]   [Full Text] [Related]  

  • 2. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Lu X; Jing L; Liu S; Wang H; Chen B
    Int J Endocrinol; 2022; 2022():5006123. PubMed ID: 35719192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.
    Jiang N; Li D; Han Y; Luo ZG; Liu LB
    Aging (Albany NY); 2024 Jun; 16(11):9784-9812. PubMed ID: 38848146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma.
    Wang J; Huang W; Chai S; Gan J; Zeng Y; Long P; Pang L
    Sci Rep; 2024 Oct; 14(1):23773. PubMed ID: 39390018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma.
    Chen J; Wu S; Wang J; Han C; Zhao L; He K; Jia Y; Cui M
    J Cell Mol Med; 2023 Jun; 27(12):1708-1724. PubMed ID: 37246638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
    Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MCMs in Endometrial Cancer and its Biological Correlation Analysis.
    Zhen Y; Fu H; Si L; Lai T; Chu D; Guo R
    Comb Chem High Throughput Screen; 2023; 26(4):815-825. PubMed ID: 35792121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients.
    Liu Q; Yu M; Zhang T
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.
    Liu J; Yin J; Wang Y; Cai L; Geng R; Du M; Zhong Z; Ni S; Huang X; Yu H; Bai J
    Biol Proced Online; 2022 Jul; 24(1):9. PubMed ID: 35836132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
    Li J; Xu W; Zhu Y
    Oncol Lett; 2020 Nov; 20(5):255. PubMed ID: 32994818
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
    Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker.
    Li Y; Gao W; Yang Z; Hu Z; Li J
    Sci Rep; 2024 Mar; 14(1):6517. PubMed ID: 38499612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
    He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
    Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma.
    Tang J; Tian X; Min J; Hu M; Hong L
    Front Oncol; 2022; 12():957472. PubMed ID: 36091104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.
    Tian Y; Wen F; Wang S; Lv N
    Clinics (Sao Paulo); 2022; 77():100103. PubMed ID: 36116266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.
    Ye Y; Li H; Bian J; Wang L; Wang Y; Huang H
    Int J Gen Med; 2021; 14():9067-9081. PubMed ID: 34876842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration.
    Wang X; Fang A; Peng Y; Yu J; Yu C; Xie J; Zheng Y; Song L; Li P; Li J; Kang X; Lin Y; Li W
    J Cell Mol Med; 2023 Mar; 27(5):609-621. PubMed ID: 36756714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
    Front Genet; 2020; 11():595733. PubMed ID: 33324448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.